GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Waypoint Biomedical Holdings Inc (OTCPK:WYPH) » Definitions » Equity-to-Asset

Waypoint Biomedical Holdings (Waypoint Biomedical Holdings) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to . Start your Free Trial

What is Waypoint Biomedical Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Waypoint Biomedical Holdings's Total Stockholders Equity for the quarter that ended in . 20 was $0.00 Mil. Waypoint Biomedical Holdings's Total Assets for the quarter that ended in . 20 was $0.00 Mil.

The historical rank and industry rank for Waypoint Biomedical Holdings's Equity-to-Asset or its related term are showing as below:

WYPH's Equity-to-Asset is not ranked *
in the Diversified Financial Services industry.
Industry Median: 0.81
* Ranked among companies with meaningful Equity-to-Asset only.

Waypoint Biomedical Holdings Equity-to-Asset Historical Data

The historical data trend for Waypoint Biomedical Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waypoint Biomedical Holdings Equity-to-Asset Chart

Waypoint Biomedical Holdings Annual Data
Trend
Equity-to-Asset

Waypoint Biomedical Holdings Quarterly Data
Equity-to-Asset

Competitive Comparison of Waypoint Biomedical Holdings's Equity-to-Asset

For the Shell Companies subindustry, Waypoint Biomedical Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Waypoint Biomedical Holdings's Equity-to-Asset Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Waypoint Biomedical Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Waypoint Biomedical Holdings's Equity-to-Asset falls into.



Waypoint Biomedical Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Waypoint Biomedical Holdings's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

Waypoint Biomedical Holdings's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Waypoint Biomedical Holdings  (OTCPK:WYPH) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Waypoint Biomedical Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Waypoint Biomedical Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Waypoint Biomedical Holdings (Waypoint Biomedical Holdings) Business Description

Traded in Other Exchanges
N/A
Address
370 Amapola Avenue, Suite 200-A, Torrance, CA, USA, 90501
Waypoint Biomedical Holdings Inc is a shell company.

Waypoint Biomedical Holdings (Waypoint Biomedical Holdings) Headlines

No Headlines